Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells

Vinit Kumar, Samer Bayda, Mohamad Hadla, Isabella Caligiuri, Concetta Russo Spena, Stefano Palazzolo, Susanne Kempter, Giuseppe Corona, Giuseppe Toffoli, Flavio Rizzolio

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In cancer therapy, it is imperative to increase the efficacy and reduce side effects of chemotherapeutic drugs. Nanotechnology offers the unique opportunity to overcome these barriers. In particular, in the last few years, DNA nanostructures have gained attention for their biocompatibility, easy customized synthesis and ability to deliver drugs to cancer cells. Here, an open-caged pyramidal DNA at Doxorubicin (Py-Doxo) nanostructure was constructed with 10 DNA sequences of 26-28 nucleotides for drug delivery to cancer cells. The synthesized DNA nanostructures are sufficiently stable in biological medium. Py-Doxo exhibited significantly enhanced cytotoxicity of the delivered doxorubicin to breast and liver cancer cells up to twofold compared to free doxorubicin. This study demonstrates the importance of the shape and structure of the designed transporter DNA nanostructures for biomedical applications.

Original languageEnglish
Pages (from-to)106-110
Number of pages5
JournalJournal of Cellular Physiology
Volume231
Issue number1
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Nanostructures
Doxorubicin
Cells
DNA
Neoplasms
Nanotechnology
DNA sequences
Liver Neoplasms
Cytotoxicity
Drug-Related Side Effects and Adverse Reactions
Drug delivery
Biocompatibility
Pharmaceutical Preparations
Liver
Nucleotides
Breast Neoplasms
doxorubicin-DNA
Therapeutics

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Cell Biology
  • Physiology
  • Medicine(all)

Cite this

Kumar, V., Bayda, S., Hadla, M., Caligiuri, I., Russo Spena, C., Palazzolo, S., ... Rizzolio, F. (2016). Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells. Journal of Cellular Physiology, 231(1), 106-110. https://doi.org/10.1002/jcp.25057

Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells. / Kumar, Vinit; Bayda, Samer; Hadla, Mohamad; Caligiuri, Isabella; Russo Spena, Concetta; Palazzolo, Stefano; Kempter, Susanne; Corona, Giuseppe; Toffoli, Giuseppe; Rizzolio, Flavio.

In: Journal of Cellular Physiology, Vol. 231, No. 1, 01.01.2016, p. 106-110.

Research output: Contribution to journalArticle

Kumar, V, Bayda, S, Hadla, M, Caligiuri, I, Russo Spena, C, Palazzolo, S, Kempter, S, Corona, G, Toffoli, G & Rizzolio, F 2016, 'Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells', Journal of Cellular Physiology, vol. 231, no. 1, pp. 106-110. https://doi.org/10.1002/jcp.25057
Kumar, Vinit ; Bayda, Samer ; Hadla, Mohamad ; Caligiuri, Isabella ; Russo Spena, Concetta ; Palazzolo, Stefano ; Kempter, Susanne ; Corona, Giuseppe ; Toffoli, Giuseppe ; Rizzolio, Flavio. / Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells. In: Journal of Cellular Physiology. 2016 ; Vol. 231, No. 1. pp. 106-110.
@article{c19292c2e26f4ad99704347f38a995ce,
title = "Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells",
abstract = "In cancer therapy, it is imperative to increase the efficacy and reduce side effects of chemotherapeutic drugs. Nanotechnology offers the unique opportunity to overcome these barriers. In particular, in the last few years, DNA nanostructures have gained attention for their biocompatibility, easy customized synthesis and ability to deliver drugs to cancer cells. Here, an open-caged pyramidal DNA at Doxorubicin (Py-Doxo) nanostructure was constructed with 10 DNA sequences of 26-28 nucleotides for drug delivery to cancer cells. The synthesized DNA nanostructures are sufficiently stable in biological medium. Py-Doxo exhibited significantly enhanced cytotoxicity of the delivered doxorubicin to breast and liver cancer cells up to twofold compared to free doxorubicin. This study demonstrates the importance of the shape and structure of the designed transporter DNA nanostructures for biomedical applications.",
author = "Vinit Kumar and Samer Bayda and Mohamad Hadla and Isabella Caligiuri and {Russo Spena}, Concetta and Stefano Palazzolo and Susanne Kempter and Giuseppe Corona and Giuseppe Toffoli and Flavio Rizzolio",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/jcp.25057",
language = "English",
volume = "231",
pages = "106--110",
journal = "Journal of cellular and comparative physiology",
issn = "0021-9541",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Enhanced Chemotherapeutic Behavior of Open-Caged DNA at Doxorubicin Nanostructures for Cancer Cells

AU - Kumar, Vinit

AU - Bayda, Samer

AU - Hadla, Mohamad

AU - Caligiuri, Isabella

AU - Russo Spena, Concetta

AU - Palazzolo, Stefano

AU - Kempter, Susanne

AU - Corona, Giuseppe

AU - Toffoli, Giuseppe

AU - Rizzolio, Flavio

PY - 2016/1/1

Y1 - 2016/1/1

N2 - In cancer therapy, it is imperative to increase the efficacy and reduce side effects of chemotherapeutic drugs. Nanotechnology offers the unique opportunity to overcome these barriers. In particular, in the last few years, DNA nanostructures have gained attention for their biocompatibility, easy customized synthesis and ability to deliver drugs to cancer cells. Here, an open-caged pyramidal DNA at Doxorubicin (Py-Doxo) nanostructure was constructed with 10 DNA sequences of 26-28 nucleotides for drug delivery to cancer cells. The synthesized DNA nanostructures are sufficiently stable in biological medium. Py-Doxo exhibited significantly enhanced cytotoxicity of the delivered doxorubicin to breast and liver cancer cells up to twofold compared to free doxorubicin. This study demonstrates the importance of the shape and structure of the designed transporter DNA nanostructures for biomedical applications.

AB - In cancer therapy, it is imperative to increase the efficacy and reduce side effects of chemotherapeutic drugs. Nanotechnology offers the unique opportunity to overcome these barriers. In particular, in the last few years, DNA nanostructures have gained attention for their biocompatibility, easy customized synthesis and ability to deliver drugs to cancer cells. Here, an open-caged pyramidal DNA at Doxorubicin (Py-Doxo) nanostructure was constructed with 10 DNA sequences of 26-28 nucleotides for drug delivery to cancer cells. The synthesized DNA nanostructures are sufficiently stable in biological medium. Py-Doxo exhibited significantly enhanced cytotoxicity of the delivered doxorubicin to breast and liver cancer cells up to twofold compared to free doxorubicin. This study demonstrates the importance of the shape and structure of the designed transporter DNA nanostructures for biomedical applications.

UR - http://www.scopus.com/inward/record.url?scp=84942342255&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942342255&partnerID=8YFLogxK

U2 - 10.1002/jcp.25057

DO - 10.1002/jcp.25057

M3 - Article

VL - 231

SP - 106

EP - 110

JO - Journal of cellular and comparative physiology

JF - Journal of cellular and comparative physiology

SN - 0021-9541

IS - 1

ER -